İmportance of Scattered White Spots Detected in the Duodenum and Their Relationship wıth Zonulin
1 other identifier
interventional
93
1 country
1
Brief Summary
With our study, we aimed to determine whether there is a correlation between zonulin, which plays a crucial role in intestinal barrier function and is implicated in the etiopathogenesis of many chronic and autoimmune diseases, and scattered white spots lesions associated with lymphatic stasis and inflammation in the duodenum.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2023
CompletedFirst Submitted
Initial submission to the registry
December 29, 2023
CompletedFirst Posted
Study publicly available on registry
January 10, 2024
CompletedJanuary 10, 2024
December 1, 2023
3 months
December 29, 2023
December 29, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
zonulin levels
Patients with scattered white spots in the duodenum had blood drawn for zonulin level immediately after the procedure.
immediately after the procedure
Secondary Outcomes (1)
Duodenal and gastric pathologic conditions
During the endoscopy
Study Arms (3)
sws grade 1
EXPERIMENTALThe group that defined as scattered white spots on the normal duodenal mucosa that could not be wiped away by washing, appearing as white spots
sws grade 2
EXPERIMENTALThe group that defined as a diffuse or patchy white appearance on villi that could not be wiped away by washing on the mucosa.
control
EXPERIMENTALThe group with a normal appearance of the duodenal mucosa, where scattered white spots were not detected.
Interventions
Blood for zonulin level was drawn from the group of patients with typical white lesions in the duodenum, called grade 1.
Blood for zonulin level was drawn from the group of patients with typical white lesions in the duodenum, called grade 2
Group of patients without scattered white lesions in the dueodenum on endoscopy.
Eligibility Criteria
You may qualify if:
- Patients with scattered white patchy lesions in the duodenum on endoscopy and control group patients with normal duodenum on endoscopy.
You may not qualify if:
- active gastroenteritis
- acute kidney failure
- chronic kidney failure
- type-1 diabetes
- inflammatory bowel disease
- duodenal ulcer,
- duodenal tumor
- autoimmune diseases
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital
Ankara, Turkey (Türkiye)
Related Publications (3)
Tas A, Koklu S, Beyazit Y, Akbal E, Kocak E, Celik H, Biyikoglu I. The endoscopic course of scattered white spots in the descending duodenum: a prospective study. Gastroenterol Hepatol. 2012 Feb;35(2):57-64. doi: 10.1016/j.gastrohep.2011.11.010. Epub 2012 Jan 20.
PMID: 22260755RESULTFasano A, Shea-Donohue T. Mechanisms of disease: the role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases. Nat Clin Pract Gastroenterol Hepatol. 2005 Sep;2(9):416-22. doi: 10.1038/ncpgasthep0259.
PMID: 16265432RESULTBiyikoglu I, Babali A, Cakal B, Koklu S, Filik L, Astarci MH, Ustun H, Ustundag Y, Akbal E. Do scattered white spots in the duodenum mark a specific gastrointestinal pathology? J Dig Dis. 2009 Nov;10(4):300-4. doi: 10.1111/j.1751-2980.2009.00399.x.
PMID: 19906109RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
semih sezer
clinic physician
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- clinic physician
Study Record Dates
First Submitted
December 29, 2023
First Posted
January 10, 2024
Study Start
September 1, 2023
Primary Completion
December 1, 2023
Study Completion
December 1, 2023
Last Updated
January 10, 2024
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will not share